Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-24

Clinical Trial Update: A Study of Tirzepatide in Participants With Impaired Liver Function [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating tirzepatide in participants with impaired liver function has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Hepatic Insufficiency | Phase 1 | Status: COMPLETED | Results posted: 2023-03-24